Neuroprotective Therapy for Stroke and Ischemic Disease eBook
Readzis program recommandation

Neuroprotective Therapy for Stroke and Ischemic Disease

Paul A. Lapchak, John H. Zhang

  • Springer

  • Publication date : 2017-01-12

Ce livre est accessible aux handicaps Voir les informations d'accessibilité
Add to basket
£159,50
Download | LCP DRM 🛈 Adobe DRM 🛈
Streaming
Add to my wish list
Image Louise Reader présentation

Louise Reader

Read on Louise Reader App.

badge apple Application Louise Reader
badge Android Application Louise Reader
Get  £23.92  by recommending this book

A critical and comprehensive look at current state-of-the-art scientific and translational research being conducted internationally, in academia and industry, to address new ways to provide effective treatment to victims of ischemic and hemorrhagic stroke and other ischemic diseases. Currently stroke can be successfully treated through the administration of a thrombolytic, but the therapeutic window is short and many patients are not able to receive treatment. Only about 30% of patients are "cured" by available treatments. In 5 sections, the proposed volume will explore historical and novel neuroprotection mechanisms and targets, new and combination therapies, as well as clinical trial design for some of the recent bench-side research.

About the book
Author
Paul A.  Lapchak , John H.  Zhang
Imprint
Springer
Collection
n.c
Publication date
2017-01-12
Pages
795 pages
Print ISBN
9783319453446
Language
English
Ebook informations
EAN PDF
9783319453453
Price
£159.50
Read more
Copy count 7
Print count 79
File size 18698 Ko
Ce livre est accessible aux handicaps   Informations accessibility
EAN EPUB
9783319453453
Price
£159.50
Read more
Copy count 7
Print count 79
File size 8141 Ko
Ce livre est accessible aux handicaps   Informations accessibility
Compatibility

mobile-and-tablet To check the compatibility with your devices,
see help page

About author(s)


Defaut-Illustration Paul A. Lapchak
Defaut-Illustration John H. Zhang
Paul Lapchak is the director of translational neurodegenerative disease research at Cedars-Sinai Medical Center in California. Dr. Lapchak obtained his Ph.D. at McGill University and University of Southern California. His lab focuses on developing new therapeutic approaches to treat different types of stroke as well as experimenting with neuroprotective agents. In addition, his research extends to drug development using the rabbit embolic stroke model and multiple assay methods. Dr. Lapchak is editor-in-chief of the Journal of Neurology & Neurophysiology and associate editor of the journal Translational Stroke Research. With over twenty years of experience and numerous publications, Dr. Lapchak is a leading expert in his field of translational stroke research.

John Zhang is doctor and professor in the departments of Anesthesiology, Neurosurgery, Neurology, and Physiology at the Loma Linda University School of Medicine in California. He obtained his Ph.D. at the University of Alberta, Canada and his MD at Chongqing University of Medical Sciences, China. His lab focuses on hemorrhagic and ischemic stroke, specifically on cerebral vascular biology, neuroprotection, gene therapy, signaling pathways, and apoptosis. Dr. Zhang is on the editorial boards of the journals Surgical Neurology and Neurological Research. Coauthor of countless publications, Dr. Zhang is also a member of several professional societies and participates in current discussions of stroke disease research and neuroprotection.

You may also be interested in...

Sign up to get our latest ebook recommendations and special offers


Paiements sécurisés

Copyright © Numilog 2025, All rights reserved